Abstract

Breast cancer is a heterogeneous disease, and its spread involves a succession of clinical and pathological stages. Screening is predominantly based on mammography, which has critical limitations related to the effectiveness and production of false-positive or false-negative results, generating discomfort and low adherence. In this context, infrared with attenuated total reflection Fourier transform infrared (ATR FT-IR) spectroscopy emerges as a non-destructive sample tool, which is non-invasive, label-free, has a low operating-cost, and requires only a small amount of sample, including liquid plasma samples. We sought to evaluate the clinical applicability of ATR FT-IR in breast cancer screening. ATR FT-IR spectroscopy through its highest potential spectral biomarker could distinguish, by liquid plasma biopsy, breast cancer patients and healthy controls, obtaining a sensitivity of 97%, specificity of 93%, a receiver operating characteristic ROC curve of 97%, and a prediction accuracy of 94%. The main variance between the groups was mainly in the band 1511 cm⁻¹ of the control group, 1502 and 1515 cm⁻¹ of the cancer group, which are the peaks of the bands referring to proteins and amide II. ATR FT-IR spectroscopy has demonstrated to be a promising tool for breast cancer screening, given its time efficiency, cost of approach, and its high ability to distinguish between the liquid plasma samples of breast cancer patients and healthy controls.

© 2023 The Author(s)

Terahertz pulsed spectroscopy of freshly excised human breast cancer

Philip C. Ashworth, Emma Pickwell-MacPherson, Elena Provenzano, Sarah E. Pinder, Anand D. Purushotham, Michael Pepper, and Vincent P. Wallace
Opt. Express 17(15) 12444-12454 (2009)

Canine cancer screening via ultraviolet absorbance and fluorescence spectroscopy of serum proteins

Bryan D. Dickerson, Brian L. Geist, William B. Spillman, Jr., and John L. Robertson
Appl. Opt. 46(33) 8080-8088 (2007)

Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy

Mirella L. Altoe, Alessandro Marone, Hyun K. Kim, Kevin Kalinsky, Dawn L. Hershman, Andreas H. Hielscher, and Richard S. Ha
Biomed. Opt. Express 10(8) 4305-4315 (2019)

Colorectal cancer detection by gold nanoparticle based surface-enhanced Raman spectroscopy of blood serum and statistical analysis

Duo Lin, Shangyuan Feng, Jianji Pan, Yanping Chen, Juqiang Lin, Guannan Chen, Shusen Xie, Haishan Zeng, and Rong Chen
Opt. Express 19(14) 13565-13577 (2011)

Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy

Gabriel Ramirez, Ashley R. Proctor, Ki Won Jung, Tong Tong Wu, Songfeng Han, Russell R. Adams, Jingxuan Ren, Daniel K. Byun, Kelley S. Madden, Edward B. Brown, Thomas H. Foster, Parisa Farzam, Turgut Durduran, and Regine Choe
Biomed. Opt. Express 7(9) 3610-3630 (2016)